WAGNER CHARLES F JR — SEC insider filings
SEC reporting owner CIK 1223348. 47 insider filings on record with FilingPulse; latest filed 2026-11-16.
Transaction summary — filings shown
Covers all 47 filings on record, filed 2021-02-05 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 46 legs across 16 filings — 75,178 shares, $32,417,067 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 56.
- Largest priced transaction: sale of 15,286 shares @ $547.87 ($8,374,741) in VERTEX PHARMACEUTICALS INC / MA, filed 2026-11-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, CO & FO | 43 | — | 46 legs · 75,178 sh · $32,417,067 | 42 |
| TJX COMPANIES INC /DE/ (TJX) | Director | 4 | — | — | 14 |
Insider filings — WAGNER CHARLES F JR
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-16 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 15,286 @ $547.87 | EDGAR |
| 2026-06-11 | 4 | TJX COMPANIES INC /DE/ (TJX) | Grant/award (A): 636.87 (derivative) @ $0 · Grant/award (A): 26.50 (derivative) @ $0 · Grant/award (A): 636.87 (derivative) @ $0 · Grant/award (A): 26.50 (derivative) @ $0 | EDGAR |
| 2026-02-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 1,744 @ $485.11 | EDGAR |
| 2026-02-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 7,365 @ $0 · Tax withholding (F): 2,294 @ $483.75 | EDGAR |
| 2026-02-18 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 4,565 @ $487.76 | EDGAR |
| 2026-02-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 3,045 @ $468.41 | EDGAR |
| 2026-01-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 9,440 @ $0 · Grant/award (A): 4,160 @ $0 | EDGAR |
| 2026-01-08 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Option exercise (M): 9,532 @ $189.38 · Sale (S): 9,532 @ $461 · Option exercise (M): 9,532 (derivative) @ $0 | EDGAR |
| 2025-12-05 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 7,000 @ $451 · Sale (S): 7,000 @ $461 | EDGAR |
| 2025-06-12 | 4 | TJX COMPANIES INC /DE/ (TJX) | Grant/award (A): 793.40 (derivative) @ $0 · Grant/award (A): 20.60 (derivative) @ $0 · Grant/award (A): 793.40 (derivative) @ $0 · Grant/award (A): 20.60 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 3,298 @ $500 | EDGAR |
| 2025-02-28 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 4,962 @ $479.61 | EDGAR |
| 2025-02-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 3,310 @ $483.28 | EDGAR |
| 2025-02-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,293 @ $463.46 | EDGAR |
| 2025-02-14 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 6,655 @ $0 | EDGAR |
| 2025-02-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,649 @ $467.98 | EDGAR |
| 2025-02-06 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 10,262 @ $0 · Grant/award (A): 7,114 @ $0 | EDGAR |
| 2024-11-13 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 3,000 @ $518.27 | EDGAR |
| 2024-06-06 | 4 | TJX COMPANIES INC /DE/ (TJX) | Grant/award (A): 944.55 (derivative) @ $0 · Grant/award (A): 9.35 (derivative) @ $0 · Grant/award (A): 944.55 (derivative) @ $0 · Grant/award (A): 9.35 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 3,250 @ $460 | EDGAR |
| 2024-05-30 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 3,250 @ $454.79 | EDGAR |
| 2024-02-27 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 3,309 @ $431.79 | EDGAR |
| 2024-02-21 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 3,750 @ $424.01 · Tax withholding (F): 2,812 @ $420.58 | EDGAR |
| 2024-02-13 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,607 @ $422.74 | EDGAR |
| 2024-02-08 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 5,814 @ $0 · Grant/award (A): 9,440 @ $0 · Grant/award (A): 7,114 @ $0 | EDGAR |
| 2024-01-04 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 3,000 @ $405 | EDGAR |
| 2023-11-21 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 3,000 @ $349.88 | EDGAR |
| 2023-09-22 | 4 | TJX COMPANIES INC /DE/ (TJX) | Grant/award (A): 721.35 (derivative) @ $0 · Grant/award (A): 721.35 (derivative) @ $0 | EDGAR |
| 2023-03-28 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 1,768 @ $305.38 | EDGAR |
| 2023-03-21 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 360 @ $294.52 · Sale (S): 784 @ $295.43 · Sale (S): 240 @ $296.30 · Sale (S): 360 @ $298.09 · Sale (S): 240 @ $299.58 · Sale (S): 16 @ $301.13 | EDGAR |
| 2023-03-14 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 361 @ $286.64 · Sale (S): 515 @ $287.83 · Sale (S): 327 @ $288.91 · Sale (S): 30 @ $289.44 · Sale (S): 541 @ $291.47 · Sale (S): 185 @ $292.68 · +8 more | EDGAR |
| 2023-02-28 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 3,308 @ $289.12 | EDGAR |
| 2023-02-22 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 3,750 @ $292.85 | EDGAR |
| 2023-02-14 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,707 @ $294.33 · Tax withholding (F): 4,992 @ $298.26 | EDGAR |
| 2023-02-03 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 10,324 @ $0 · Grant/award (A): 10,262 @ $0 · Grant/award (A): 9,440 @ $0 | EDGAR |
| 2022-05-04 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 20 @ $254.87 · Sale (S): 100 @ $257.18 · Sale (S): 60 @ $258.21 · Sale (S): 80 @ $259.45 · Sale (S): 48 @ $261.15 · Sale (S): 32 @ $262.06 · +1 more | EDGAR |
| 2022-05-03 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 547 @ $276.17 | EDGAR |
| 2022-04-05 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 300 @ $261.42 · Sale (S): 381 @ $263.67 · Sale (S): 1,142 @ $265.06 · Sale (S): 536 @ $265.95 · Sale (S): 223 @ $266.68 | EDGAR |
| 2022-03-21 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 3,110 @ $250.13 · Sale (S): 61 @ $251.05 | EDGAR |
| 2022-02-28 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,189 @ $227.86 | EDGAR |
| 2022-02-22 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 3,439 @ $232.51 | EDGAR |
| 2022-02-14 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,434 @ $237.74 | EDGAR |
| 2022-02-03 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 3,698 @ $0 · Grant/award (A): 11,628 @ $0 · Grant/award (A): 10,262 @ $0 · Sale (S): 2,944 @ $250.07 | EDGAR |
| 2021-05-05 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 547 @ $217.21 | EDGAR |
| 2021-02-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 547 @ $217.57 | EDGAR |
| 2021-02-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,365 @ $214.16 | EDGAR |
| 2021-02-05 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 10,324 @ $0 · Grant/award (A): 11,627 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1223348 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs